Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Submitted by
admin
on March 2, 2018 - 11:08am
Source:
Endpoints
News Tags:
Biogen
AbbVie
MS
multiple sclerosis
Zinbryta
Europe
encephalitis
Headline:
Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Do Not Allow Advertisers to Use My Personal information
